L-아르기닌 시장(2026-2030년)

The global l-arginine market is forecasted to grow by USD 379.8 mn during 2025-2030, accelerating at a CAGR of 7.6% during the forecast period. The report on the global l-arginine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising consumer demand for sports nutrition and performance enhancers, technological advancements in biotechnological production methods, expanding applications in pharmaceutical and clinical nutrition.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global l-arginine market is segmented as below:

By Application

• Nutrition and supplements
• Pharmaceuticals
• Cosmetics

By Grade Type

• Food grade
• Pharma grade

By Form Factor

• Powder
• Capsules
• Liquid

By Distribution Channel

• Offline
• Online

Geography

• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Middle East and Africa
  • South Africa
  • UAE
  • Egypt
• South America
  • Brazil
  • Argentina
  • Chile
• Rest of World (ROW)

This study identifies the rise of fermentation-based sustainable manufacturing as one of the prime reasons driving the global l-arginine market growth during the next few years. Also, integration of l-arginine in personal care and beauty formulations and shift toward personalized nutrition and targeted delivery systems will lead to sizable demand in the market.

The report on the global l-arginine market covers the following areas:

• Global l-arginine market sizing
• Global l-arginine market forecast
• Global l-arginine market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global l-arginine market vendors that include Ajinomoto Co. Inc., Bachem AG, Cayman Chemical Co., China Amino Acid Co. Ltd., Daesang Corp., Doctors Best, Evonik Industries AG, Glanbia Plc, Jarrow Formulas Inc., Kyowa Hakko USA Inc., Life Extension, Meihua Holdings Group Co. Ltd., Merck KGaA, NOW Health Group Inc., Prinova Group LLC, Starry Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., Tokyo Chemical Industry Co.. Also, the global l-arginine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Grade Type
  • Executive Summary - Chart on Market Segmentation by Form Factor
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global L-Arginine Market 2020 - 2024
  • Historic Market Size - Data Table on Global L-Arginine Market 2020 - 2024 ($ million)
• 5.2 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.3 Grade Type segment analysis 2020 - 2024
  • Historic Market Size - Grade Type Segment 2020 - 2024 ($ million)
• 5.4 Form Factor segment analysis 2020 - 2024
  • Historic Market Size - Form Factor Segment 2020 - 2024 ($ million)
• 5.5 Distribution Channel segment analysis 2020 - 2024
  • Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
• 5.6 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.7 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global L-arginine market
• 6.2 Impact of geopolitical conflicts on global L-arginine market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Application

• 8.1 Market segments
• 8.2 Comparison by Application
• 8.3 Nutrition and supplements - Market size and forecast 2025-2030
• 8.4 Pharmaceuticals - Market size and forecast 2025-2030
• 8.5 Cosmetics - Market size and forecast 2025-2030
• 8.6 Market opportunity by Application
  • Market opportunity by Application ($ million)

9 Market Segmentation by Grade Type

• 9.1 Market segments
• 9.2 Comparison by Grade Type
• 9.3 Food grade - Market size and forecast 2025-2030
• 9.4 Pharma grade - Market size and forecast 2025-2030
• 9.5 Market opportunity by Grade Type
  • Market opportunity by Grade Type ($ million)

10 Market Segmentation by Form Factor

• 10.1 Market segments
• 10.2 Comparison by Form Factor
• 10.3 Powder - Market size and forecast 2025-2030
• 10.4 Capsules - Market size and forecast 2025-2030
• 10.5 Liquid - Market size and forecast 2025-2030
• 10.6 Market opportunity by Form Factor
  • Market opportunity by Form Factor ($ million)

11 Market Segmentation by Distribution Channel

• 11.1 Market segments
• 11.2 Comparison by Distribution Channel
• 11.3 Offline - Market size and forecast 2025-2030
• 11.4 Online - Market size and forecast 2025-2030
• 11.5 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)

12 Customer Landscape

• 12.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

• 13.1 Geographic segmentation
• 13.2 Geographic comparison
• 13.3 APAC - Market size and forecast 2025-2030
  • 13.3.1 China - Market size and forecast 2025-2030
  • 13.3.2 Japan - Market size and forecast 2025-2030
  • 13.3.3 India - Market size and forecast 2025-2030
  • 13.3.4 South Korea - Market size and forecast 2025-2030
  • 13.3.5 Australia - Market size and forecast 2025-2030
  • 13.3.6 Thailand - Market size and forecast 2025-2030
• 13.4 North America - Market size and forecast 2025-2030
  • 13.4.1 US - Market size and forecast 2025-2030
  • 13.4.2 Canada - Market size and forecast 2025-2030
  • 13.4.3 Mexico - Market size and forecast 2025-2030
• 13.5 Europe - Market size and forecast 2025-2030
  • 13.5.1 Germany - Market size and forecast 2025-2030
  • 13.5.2 UK - Market size and forecast 2025-2030
  • 13.5.3 France - Market size and forecast 2025-2030
  • 13.5.4 Italy - Market size and forecast 2025-2030
  • 13.5.5 Spain - Market size and forecast 2025-2030
  • 13.5.6 The Netherlands - Market size and forecast 2025-2030
• 13.6 Middle East and Africa - Market size and forecast 2025-2030
  • 13.6.1 Saudi Arabia - Market size and forecast 2025-2030
  • 13.6.2 South Africa - Market size and forecast 2025-2030
  • 13.6.3 UAE - Market size and forecast 2025-2030
  • 13.6.4 Egypt - Market size and forecast 2025-2030
  • 13.6.5 Israel - Market size and forecast 2025-2030
• 13.7 South America - Market size and forecast 2025-2030
  • 13.7.1 Brazil - Market size and forecast 2025-2030
  • 13.7.2 Argentina - Market size and forecast 2025-2030
  • 13.7.3 Chile - Market size and forecast 2025-2030
• 13.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

14 Drivers, Challenges, and Opportunity

• 14.1 Market drivers
  • Rising consumer demand for sports nutrition and performance enhancers
  • Technological advancements in biotechnological production methods
  • Expanding applications in pharmaceutical and clinical nutrition
• 14.2 Market challenges
  • Stringent regulatory compliance and standardization
  • Volatility in raw material costs and supply chain fragility
  • Rising competition from bioavailable substitutes and alternative compounds
• 14.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 14.4 Market opportunities
  • Rise of fermentation-based sustainable manufacturing
  • Integration of L-arginine in personal care and beauty formulations
  • Shift toward personalized nutrition and targeted delivery systems

15 Competitive Landscape

• 15.1 Overview
• 15.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 15.3 Landscape disruption
  • Overview on factors of disruption
• 15.4 Industry risks
  • Impact of key risks on business

16 Competitive Analysis

• 16.1 Companies profiled
  • Companies covered
• 16.2 Company ranking index
  • Company ranking index
• 16.3 Market positioning of companies
  • Matrix on companies position and classification
• 16.4 Ajinomoto Co. Inc.
  • Ajinomoto Co. Inc. - Overview
  • Ajinomoto Co. Inc. - Business segments
  • Ajinomoto Co. Inc. - Key offerings
  • Ajinomoto Co. Inc. - Segment focus
  • SWOT
• 16.5 Bachem AG
  • Bachem AG - Overview
  • Bachem AG - Business segments
  • Bachem AG - Key news
  • Bachem AG - Key offerings
  • Bachem AG - Segment focus
  • SWOT
• 16.6 Cayman Chemical Co.
  • Cayman Chemical Co. - Overview
  • Cayman Chemical Co. - Product / Service
  • Cayman Chemical Co. - Key offerings
  • SWOT
• 16.7 China Amino Acid Co. Ltd.
  • China Amino Acid Co. Ltd. - Overview
  • China Amino Acid Co. Ltd. - Product / Service
  • China Amino Acid Co. Ltd. - Key offerings
  • SWOT
• 16.8 Daesang Corp.
  • Daesang Corp. - Overview
  • Daesang Corp. - Business segments
  • Daesang Corp. - Key offerings
  • Daesang Corp. - Segment focus
  • SWOT
• 16.9 Doctors Best
  • Doctors Best - Overview
  • Doctors Best - Product / Service
  • Doctors Best - Key offerings
  • SWOT
• 16.10 Evonik Industries AG
  • Evonik Industries AG - Overview
  • Evonik Industries AG - Business segments
  • Evonik Industries AG - Key offerings
  • Evonik Industries AG - Segment focus
  • SWOT
• 16.11 Glanbia Plc
  • Glanbia Plc - Overview
  • Glanbia Plc - Business segments
  • Glanbia Plc - Key offerings
  • Glanbia Plc - Segment focus
  • SWOT
• 16.12 Jarrow Formulas Inc.
  • Jarrow Formulas Inc. - Overview
  • Jarrow Formulas Inc. - Product / Service
  • Jarrow Formulas Inc. - Key offerings
  • SWOT
• 16.13 Kyowa Hakko USA Inc.
  • Kyowa Hakko USA Inc. - Overview
  • Kyowa Hakko USA Inc. - Product / Service
  • Kyowa Hakko USA Inc. - Key offerings
  • SWOT
• 16.14 Life Extension
  • Life Extension - Overview
  • Life Extension - Product / Service
  • Life Extension - Key offerings
  • SWOT
• 16.15 Meihua Holdings Group Co. Ltd.
  • Meihua Holdings Group Co. Ltd. - Overview
  • Meihua Holdings Group Co. Ltd. - Product / Service
  • Meihua Holdings Group Co. Ltd. - Key offerings
  • SWOT
• 16.16 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 16.17 NOW Health Group Inc.
  • NOW Health Group Inc. - Overview
  • NOW Health Group Inc. - Product / Service
  • NOW Health Group Inc. - Key offerings
  • SWOT
• 16.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

17 Appendix

• 17.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 17.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 17.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 17.4 Research methodology
  • Research methodology
• 17.5 Data procurement
  • Information sources
• 17.6 Data validation
  • Data validation
• 17.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 17.8 Data synthesis
  • Data synthesis
• 17.9 360 degree market analysis
  • 360 degree market analysis
• 17.10 List of abbreviations
  • List of abbreviations